GlassScriptPhysician profile
Douglass Morrison Hasell
NPI 1447256300
$1,701.41
in general payments reported to CMS, 2019-2025
16 companies · $292 in 2025
The $292 reported for 2025 was more than what 84% of Pediatrics providers received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $403 · 2020: $55.80 · 2021: $149 · 2022: $159 · 2023: $502 · 2024: $142 · 2025: $292.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $930 · Education: $5.17.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $930.45 |
| Education | $5.17 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Supernus Pharmaceuticals, INC. | $327.90 | 2021-2025 | Qelbree, Qelbree |
| Corium, LLC | $238.92 | 2023-2024 | Azstarys |
| Ironshore Pharmaceuticals INC. | $210.68 | 2019-2024 | |
| Merck Sharp & Dohme LLC | $207.27 | 2022-2025 | Gardasil 9, Vaxneuvance, Vaxelis |
| Pfizer INC. | $180.88 | 2019-2023 | |
| Takeda Pharmaceuticals U.S.A., INC. | $100.02 | 2020-2022 | |
| Cranial Technologies, INC | $71.91 | 2019-2025 | Doc Band |
| Sanofi Pasteur INC. | $69.37 | 2020-2025 | |
| Sanofi-Aventis U.S. LLC | $68.38 | 2025 | |
| Astrazeneca Pharmaceuticals LP | $55.59 | 2023-2024 | Flumist Quadrivalent |
| Tris Pharma INC | $53.75 | 2019-2020 | |
| Phadia US INC. | $36.87 | 2022-2023 | Immunocap |
| Cipher Pharmaceuticals US LLC | $24.65 | 2025 | Natroba, Spinosad |
| Sobi, INC | $23.05 | 2023 | |
| Novo Nordisk INC | $16.70 | 2019 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kowa Pharmaceuticals America, INC. | $15.47 | 2025 | Zoryve |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Douglass Hasell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.